THE PNC FINANCIAL SERVICES GROUP ANNOUNCES FOURTH QUARTER AND FULL YEAR EARNINGS CONFERENCE CALL DETAILS
- 67
PR Newswire
PITTSBURGH, Dec. 7, 2022
PITTSBURGH, Dec. 7, 2022 /PRNewswire/ -- The PNC Financial Services Group, Inc. (NYSE: PNC) expects to issue financial results for the fourth quarter and full year 2022, at approximately 6:30 a.m. (ET), Wednesday, Jan. 18, 2023, as previously announced. PNC Chairman, President and Chief Executive Officer William S. Demchak and Executive Vice President and Chief Financial Officer Robert Q. Reilly will hold a conference call for investors the same day at 9 a.m. (ET).
Dial in numbers are (877) 224-6304 and (303) 223-0120 (international). The following will be accessible at www.pnc.com/investorevents: a link to the live audio webcast on the day of the conference call; presentation slides, earnings release and supplementary financial information; and a webcast replay available for 30 days. A telephone replay of the call will be available for one week at (800) 633-8284 and (402) 977-9140 (international), Conference ID 22021446.
The PNC Financial Services Group, Inc. is one of the largest diversified financial services institutions in the United States, organized around its customers and communities for strong relationships and local delivery of retail and business banking including a full range of lending products; specialized services for corporations and government entities, including corporate banking, real estate finance and asset-based lending; wealth management and asset management. For information about PNC, visit www.pnc.com.
CONTACTS:
MEDIA:
Tim Miller
(412) 762-4550
[email protected]
INVESTORS:
Bryan Gill
(412) 768-4143
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-pnc-financial-services-group-announces-fourth-quarter-and-full-year-earnings-conference-call-details-301697054.html
SOURCE The PNC Financial Services Group, Inc.
PR Newswire's news distribution, targeting, monitoring and marketing solutions help you connect and engage with target audiences across the globe.
- Marex Group plc Announces Pricing of Initial Public Offering
- Labcorp Announces Winning Bid for Select Assets of Invitae
- Invitae Enters into Agreement with Labcorp for Sale of Business
- TransAlta Declares Dividends
- ASCO 2024 | Ascentage Pharma to Present Four Studies, Including an Oral Report Featuring the Latest Data of Olverembatinib in SDH-Deficient GIST
- Ero Copper Announces Voting Results of Annual General Meeting of Shareholders